Altus Wealth Group LLC Bristol Myers Squibb CO Transaction History

Altus Wealth Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 18, 2023	BUY	$68.48 - $81.09 $210,644 - $249,432	3,076 New	3,076 $0
Q2 2022 Aug 10, 2022	SELL	$72.62 - $79.98 $223,379 - $246,018	-3,076 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$61.48 - $73.72 $189,112 - $226,762	3,076 New	3,076 $225,000
Q3 2021 Nov 08, 2021	SELL	$59.17 - $69.31 $181,947 - $213,128	-3,075 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$61.91 - $67.42 $11,886 - $12,944	-192 Reduced 5.88%	3,075 $205,000
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $1,008 - $1,134	-17 Reduced 0.52%	3,267 $209,000
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $189,618 - $214,872	3,284 New	3,284 $204,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Altus Wealth Group LLC, based on Form 13F filings with the SEC.

Stay updated on Altus Wealth Group LLC with notifications on news.